Hair Relaxer Lawsuit

Hair relaxer products contain chemicals that may be absorbed through the scalp and have potential endocrine-disrupting effects. Studies have found that women who use hair relaxers have significantly higher rates of uterine cancer, ovarian cancer, and other reproductive cancers.

Frequent use of hair relaxers, particularly with regular application to the scalp, increases cumulative chemical exposure and cancer risk.

Hair relaxer chemicals appear to function as endocrine disruptors, interfering with hormone signaling pathways involved in reproductive system regulation. This hormonal disruption may increase cancer risk in hormone-sensitive tissues.

The mechanisms of cancer causation involve both direct toxic effects and disruption of normal hormonal regulation.

Manufacturers failed to adequately warn consumers about cancer risks associated with hair relaxer use. Product warnings did not include information about cancer risks or recommendations for reduced-frequency use.

Without proper warnings, particularly in communities where hair relaxer use is common, consumers could not make informed decisions about product use.

Women with a history of regular hair relaxer use who have been diagnosed with uterine cancer, ovarian cancer, or other reproductive cancers may have viable claims. Long-term users with frequent application are more likely to have successful claims.

To evaluate your case, we need information about the duration and frequency of hair relaxer use, products used, cancer diagnosis with medical documentation, and medical records relating to diagnosis and treatment.